Immunologic low-responder in ABO-incompatible renal transplant recipients explored by donor-specific platelet transfusion.
Ishibashi
M
M
Department of Urology, Hyogo College of Medicine, Japan.
Oshida
M
M
Kurata
Y
Y
Kokado
Y
Y
Takahara
S
S
Kyo
M
M
Ikoma
F
F
D000017:ABO Blood-Group System / Q000276:immunology*; D000293:Adolescent; D000328:Adult; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001787:Blood Group Incompatibility / Q000276:immunology*; D002985:Clinical Protocols; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D011239:Prednisolone / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D014019:Tissue Donors
D000017:ABO Blood-Group System; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine